Roivant Sciences Ltd (ROIV)
Receivables turnover
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 29,053 | 124,795 | 61,280 | 55,286 | 23,795 |
Receivables | US$ in thousands | — | 82,813 | 37,644 | 6,732 | 13,832 |
Receivables turnover | — | 1.51 | 1.63 | 8.21 | 1.72 |
March 31, 2025 calculation
Receivables turnover = Revenue ÷ Receivables
= $29,053K ÷ $—K
= —
The receivables turnover ratio for Roivant Sciences Ltd has shown varying trends over the past five years.
In March 2021, the receivables turnover was 1.72, indicating that the company collected its accounts receivable approximately 1.72 times during that year. This ratio increased significantly to 8.21 in March 2022, suggesting a more efficient collection of receivables compared to the previous year. However, in March 2023, the ratio decreased sharply to 1.63, signaling a potential slowdown in the collection of accounts receivable.
The trend continued in March 2024, with a further decrease to 1.51 in the receivables turnover ratio. This decline may indicate extended payment terms offered to customers or difficulties in collecting outstanding receivables promptly. Unfortunately, the data for March 31, 2025, is not available, making it challenging to provide a complete analysis for that year.
Overall, fluctuations in the receivables turnover ratio suggest variations in the company's ability to efficiently manage and collect its accounts receivable over the years, highlighting the importance of closely monitoring this ratio to assess the effectiveness of the company's credit and collection policies.
Peer comparison
Mar 31, 2025